
### [NCIT:C7749](http://purl.obolibrary.org/obo/NCIT_C7749)
**Label:** Cutaneous Fibrohistiocytic Neoplasm

**Subclasses:** [NCIT:C6801](http://purl.obolibrary.org/obo/NCIT_C6801) (Cutaneous Fibrous Histiocytoma), [NCIT:C49078](http://purl.obolibrary.org/obo/NCIT_C49078) (Cutaneous Fibrous Histiocytoma, Cellular Variant), [NCIT:C49076](http://purl.obolibrary.org/obo/NCIT_C49076) (Cutaneous Fibrous Histiocytoma, Fibroblastic Variant), [NCIT:C7344](http://purl.obolibrary.org/obo/NCIT_C7344) (Intermediate Cutaneous Fibrohistiocytic Neoplasm), [NCIT:C7343](http://purl.obolibrary.org/obo/NCIT_C7343) (Benign Cutaneous Fibrohistiocytic Neoplasm), 

**Class expressions from DL-Learner:**

- Thing 52.40%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 42.65%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40137](http://purl.obolibrary.org/obo/NCIT_C40137) (Uterine Ligament Mucinous Adenocarcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40127](http://purl.obolibrary.org/obo/NCIT_C40127) (Fallopian Tube Leiomyoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma))) 40.91%


